Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU industry challenges hip implants upgrade proposal

This article was originally published in Clinica

Executive Summary

The formal request put forward by the French and UK medical device regulatory authorities to reclassify hip joint replacements as high risk products (see Clinica No 1045, p 3) could impact the availability of these products to patients in the short term and constitute an unnecessary burden on the European medical technology industry. That is the view of the European medical devices industry association, which has issued a statement challenging the nature of the request.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061251

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel